GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis
NCT00457171
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
GI-270384
Sponsor
GlaxoSmithKline